Weld Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Weld Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,590	Closed	-$207K	–	720
2020 Q2	$207K	Buy	+4,590	New	+$206K	0.08%	379
2019 Q3	–	Sell	-4,921	Closed	-$237K	–	1112
2019 Q2	$237K	Buy	+4,921	New	+$259K	0.04%	608

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Weld Capital Management's BEAT Position: Q3 2020 in Review

Weld Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q3 2020, closing a stake of 4,590 shares — an estimated $207K sold.

Weld Capital Management first reported a position in BEAT in Q2 2019 and held it in 2 quarters. The position peaked at $237K in Q2 2019. 209 funds tracked by Wall St. Rank hold BEAT as of Q3 2020.

Weld Capital Management reported no remaining BioTelemetry, Inc. position as of Q3 2020 after selling out during the quarter.
Weld Capital Management sold 4,590 BioTelemetry, Inc. shares in Q3 2020, an estimated $207K.
Weld Capital Management first reported a position in BioTelemetry, Inc. in Q2 2019 and held it in 2 quarters.
Weld Capital Management's BioTelemetry, Inc. position peaked at $237K in Q2 2019.
209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2020.

Based on Weld Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.